Literature DB >> 29890209

Diversity of multidrug-resistant epidemic Clostridium difficile NAP1/RT027/ST01 strains in tertiary hospitals from Honduras.

Fanny Hidalgo-Villeda1, Edgardo Tzoc1, Luque Torres2, Efraín Bu3, César Rodríguez4, Carlos Quesada-Gómez5.   

Abstract

In recent years, reports of NAP1/RT027/ST01 epidemic strains of Clostridium difficile producing outbreaks of healthcare-associated diarrhea have increased in America and Europe. We cultivated multidrug-resistant NAP1/RT027/ST01 strains from the FQR2 linage from TcdA/TcdB+ stool samples obtained from patients in two Honduran hospitals. The PFGE macrorestriction patterns of two of the isolates were new. These bacteria were toxigenic and induced with different magnitude classical cytopathic effects on HeLa cells. Besides their resistance to twelve antibiotics, including to clindamycin, fluoroquinolones, linezolid and tigecycline. In this regard, they show the gyrA mutation that typifies epidemic C. difficile genotypes and carry cfr-like genes in different molecular contexts, respectively. These results confirm the spread of multidrug-resistant NAP1/RT027/ST01 strains in Central America with potential idiosyncratic adaptations.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clostridium difficile; Epidemic genotype; Linezolid; Multidrug resistance; Surveillance

Mesh:

Substances:

Year:  2018        PMID: 29890209     DOI: 10.1016/j.anaerobe.2018.06.001

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  3 in total

1.  cfr(B), cfr(C), and a New cfr-Like Gene, cfr(E), in Clostridium difficile Strains Recovered across Latin America.

Authors:  Vanja Stojković; María Fernanda Ulate; Fanny Hidalgo-Villeda; Emmanuel Aguilar; Camilo Monge-Cascante; Marjorie Pizarro-Guajardo; Kaitlyn Tsai; Edgardo Tzoc; Margarita Camorlinga; Daniel Paredes-Sabja; Carlos Quesada-Gómez; Danica Galonić Fujimori; César Rodríguez
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

2.  Origin, genomic diversity and microevolution of the Clostridium difficile B1/NAP1/RT027/ST01 strain in Costa Rica, Chile, Honduras and Mexico.

Authors:  Enzo Guerrero-Araya; Claudio Meneses; Eduardo Castro-Nallar; Ana M Guzmán D; Manuel Álvarez-Lobos; Carlos Quesada-Gómez; Daniel Paredes-Sabja; César Rodríguez
Journal:  Microb Genom       Date:  2020-03-16

3.  Toxin profiles and antimicrobial resistance patterns among toxigenic clinical isolates of Clostridioides (Clostridium) difficile.

Authors:  Hamid Heidari; Hadi Sedigh Ebrahim-Saraie; Ali Amanati; Mohammad Motamedifar; Nahal Hadi; Abdollah Bazargani
Journal:  Iran J Basic Med Sci       Date:  2019-07       Impact factor: 2.699

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.